Home > News > Analyzing nanoparticle levels in blood
May 22nd, 2007
Analyzing nanoparticle levels in blood
Abstract:
With the race to develop nanoparticle-based therapeutics and imaging agents for cancer applications moving at full speed, a small but growing group of researchers is quietly developing the methods that are needed to fully characterize a wide variety of nanoscale materials and then detect and quantify their presence in blood and other human tissues. One such effort, headed by King Chan, Ph.D., of the National Cancer Institute, and Anil Patri, Ph.D., of the Nanotechnology Characterization Laboratory, has now developed a straightforward method for analyzing two types of fullerene nanoparticle.
Source:
nanowerk.com
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Safety-Nanoparticles/Risk management
Tests find no free-standing nanotubes released from tire tread wear September 8th, 2023
Billions of nanoplastics released when microwaving baby food containers: Exposure to plastic particles kills up to 75% of cultured kidney cells July 21st, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||